| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1990487A Berberine ion pair compound, preparing method and drug containing same |
| 07/04/2007 | CN1990475A Substituted benzisoselenazolone compounds and use thereof |
| 07/04/2007 | CN1990462A Use of succinyl hydrazine compounds and compositions thereof in preparation of drug for treating leukemia |
| 07/04/2007 | CN1990039A Modification method of polymeric hemoglobin |
| 07/04/2007 | CN1990038A Method for preparing narrow distribution low-molecular-weight polymeric hemoglobin on gel blocking chromatographic column |
| 07/04/2007 | CN1990013A Traditional Chinese medicine for vein relaxing and blood consistence reducing |
| 07/04/2007 | CN1990009A Thrombus prevention and cure agent |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324015C Pyridine and pyrimidine derivatives |
| 07/04/2007 | CN1324009C Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide |
| 07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
| 07/04/2007 | CN1323713C Novel usage of soluble P-lectin and anthrax lethal toxin |
| 07/04/2007 | CN1323690C Prescription of Huanyuan Injection and its preparation process and usage |
| 07/04/2007 | CN1323687C Blood supplementing iron supplementing medicineal preparation and its preparation method |
| 07/04/2007 | CN1323585C Anti-pathogenic composition useful in blood preservation |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238667 Albumin fusion proteins |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | CA2319096C Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 06/29/2007 | CA2572057A1 A photoactive biocompatible coating composition |
| 06/28/2007 | WO2007073095A1 Process for the preparation of (s)-(+)-clopidogrel on a solid-phase |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072971A1 Agent for improving angiopathy containing sulfated polysaccharide derived from green alga and method for producing the same |
| 06/28/2007 | WO2007072911A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 06/28/2007 | WO2007072845A1 Therapeutic agent or therapeutic method for ischemic stroke |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | WO2007070899A2 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms |
| 06/28/2007 | WO2007053952B1 Platelet factor-4 (pf-4) analogs and their use |
| 06/28/2007 | WO2006052718A3 Farnesyltransferase inhibitors for treating sepsis |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 06/28/2007 | US20070148630 Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148199 Preparations for topical skin use and treatment |
| 06/28/2007 | US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | DE102005061624A1 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen An improved process for the preparation of salts of 4- (Benzimidazolylmethylamino) -Benzamidinen |
| 06/28/2007 | DE102005061623A1 Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen An improved process for preparing 4- (Benzimidazolylmethylamino) -Benzamidinen and salts thereof |
| 06/28/2007 | CA2634608A1 Inhibition de la reponse immunitaire anti-fviii |
| 06/28/2007 | CA2634026A1 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms |
| 06/28/2007 | CA2633484A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | CA2633331A1 Potentiation of apoptosis by monoclonal antibodies |
| 06/27/2007 | EP1800673A2 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/27/2007 | EP1799268A2 Magnetic particles for therapy and diagnosis |
| 06/27/2007 | EP1799267A2 Conjugates of hydroxyalkyl starch and a protein |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1220923B1 FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 06/27/2007 | CN1989245A Novel galectin 8 modification protein and use thereof |
| 06/27/2007 | CN1989146A Sulfated oligosaccharide derivatives |
| 06/27/2007 | CN1989104A Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 06/27/2007 | CN1988910A Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 06/27/2007 | CN1986525A 4-methoxy-1,3-phenyl disulfamide derivative and its application |
| 06/27/2007 | CN1985965A Medicine for treating coronary heart disease and cerebral thrombus and its preparing method |
| 06/27/2007 | CN1985880A Chinese herbal medicine for treating gastrointestinal diseases and hemophilia |
| 06/27/2007 | CN1985866A Application of Chinese medicine composition in treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985836A Medicine composition for treating cerebral ischemia |
| 06/27/2007 | CN1985662A Health beverage capable of lowering blood viscosity |
| 06/27/2007 | CN1322867C Hemostatic wound healing Dan |
| 06/27/2007 | CN1322863C Injectio for inhibiting platelet aggregation and its preparation process |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/21/2007 | WO2007070872A1 Kinase inhibitors and their uses |
| 06/21/2007 | WO2007070818A1 Six-membered heterocycles useful as serine protease inhibitors |
| 06/21/2007 | WO2007069358A1 Novel preparation of gastric retention type |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142295 Thrombopoietic compounds |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | DE102005060690A1 Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen Salts of clopidogrel with polyanions and their use for the preparation of pharmaceutical formulations |
| 06/21/2007 | CA2633035A1 Kinase inhibitors and their uses |
| 06/20/2007 | EP1798238A1 Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions |
| 06/20/2007 | EP1797080A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 06/20/2007 | EP1797079A1 Proline derivatives |
| 06/20/2007 | EP1797071A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 06/20/2007 | EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 06/20/2007 | EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |